Hepatitis c, chronic Trials in San Antonio, United States
Conditions / Hepatitis c, chronic / San Antonio, United States
Hepatitis c, chronic has been the subject of sustained clinical investigation across multiple research sites.
40 total trials for this combination
Showing top 10 of 40 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00516321 | Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease | COMPLETED | PHASE3 |
| NCT01457768 | A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response | COMPLETED | — |
| NCT01457755 | Gilead Sustained Virologic Response (SVR) Registry | COMPLETED | — |
| NCT01271790 | A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C | COMPLETED | PHASE2 |
| NCT00529568 | Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease | COMPLETED | PHASE3 |
| NCT01358864 | Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3) | COMPLETED | PHASE3 |
| NCT00703118 | A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment | COMPLETED | PHASE3 |
| NCT01168856 | An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Direct Acting Antiviral (DAA)- Containing Regimens | TERMINATED | — |
| NCT01459913 | Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype | TERMINATED | PHASE3 |
| NCT01066819 | PROPHESYS 3: Observational Study on Predictors of Response in Patients With Treatment-naïve Chronic Hepatitis C Initiated on Treatment With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b | COMPLETED | — |